PALVELLA THERAPEUTICS, INC. ($PVLA)
Filing Information
| Accession Number | 0001104659-26-099222 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 20, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
12,906
Total Value
$689,674.30
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Aug 19, 2026 | Exercise/Conversion | 2,154 | $7.14 | $15,379.56 | 2,154 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Aug 19, 2026 | Exercise/Conversion | 2,148 | $9.08 | $19,503.84 | 4,302 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Aug 19, 2026 | Sale | 1,500 | $151.39 | $227,085.00 | 2,802 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Aug 19, 2026 | Sale | 1,998 | $151.80 | $303,292.20 | 804 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Aug 19, 2026 | Sale | 400 | $153.00 | $61,199.00 | 404 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Aug 19, 2026 | Sale | 102 | $155.59 | $15,870.16 | 302 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Aug 19, 2026 | Sale | 302 | $156.77 | $47,344.54 | 0 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Aug 19, 2026 | Exercise/Conversion | 2,154 | $0.00 | $0.00 | 4,319 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Aug 19, 2026 | Exercise/Conversion | 2,148 | $0.00 | $0.00 | 4,296 | Direct | โ | View Details |